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We investigated the antiplasmodial properties of crude extracts from Carica papaya leaves to trace the activity through bioassay-
guided fractionation. The greatest antiplasmodial activity was observed in the ethyl acetate crude extract. C. papaya showed a high
selectivity for P. falciparum against CHO cells with a selectivity index of 249.25 and 185.37 in the chloroquine-sensitive D10 and
chloroquine-resistant DD2 strains, respectively. Carica papaya ethyl acetate extract was subjected to bioassay-guided fractionation
to ascertain the most active fraction, which was puriﬁed and identiﬁed using high-pressure liquid chromatography (HPLC) and
GC-MS (Gas chromatography-Mass spectrometry) methods. Linoleic and linolenic acids identiﬁed from the ethyl acetate fraction
showed IC50 of 6.88μg/ml and 3.58μg/ml, respectively. The study demonstrated greater antiplasmodial activity of the crude ethyl
acetate extract of Carica papaya leaves with an IC50 of 2.96±0.14μg/ml when compared to the activity of the fractions and isolated
compounds.
1.Introduction
Carica papaya L. of the family Caricaceae is a soft-stemmed
perennial plant. It is usually unbranched and can grow to a
height of about 20m [1]. It is believed to originate from the
Caribbean coast of Central America and over the years has
found its way into many tropical and subtropical climates
[2]. C. papaya can grow in male, female, or hermaphrodite
forms. It is found growing wild in many parts of the tropics
and is cultivated because of its sweet juicy fruit which serves
as a nutritious food with rich medicinal value and also
because of the ease with which it is digested. It commonly
features in breakfasts, cooked in diverse ways, and as ingre-
dients in jellies beverage and juice [3]. The fruits, leaves, and
latex of this species are traditionally used in diﬀerent parts
of the world to treat diverse disease conditions. It is used in
variousplacesinthetreatmentofasthma,rheumatism,fever,
diarrhea, boils, and hypertension and to increase the pro-
duction of milk in lactating individuals [4]. Previous studies
have shown that this species has promising antifungal [5],
antibacterial [6],and anthelminthic [7]p r o pe rti e s .H o w ev e r ,
studies on the in vitro antiplasmodial and cytotoxic proper-
ties of crude extracts sequentially extracted from solvents of
diﬀerent polarities are nonexistent in the literature. In this
study, Carica papaya leaves were sequentially extracted with
petroleum ether, dichloromethane, ethyl acetate, methanol,
and water in that order. The antiplasmodial and cytotoxic
activities of the extract from each solvent were investigated,
andabioassay-guidedfractionationofthemostactiveextract
was carried out.
2.MaterialsandMethods
2.1. Plant Materials. Carica papaya leaves were collected
in June 2008 and identiﬁed by a taxonomist in the Plant
Science and Biotechnology Department, Abia State Univer-
sity, Uturu, Nigeria. A voucher specimen PM/ABSU/06-63
of the plant was deposited in the herbarium of Abia State
University, Uturu, Nigeria. The Division of Pharmacology at
the University of Cape Town requested for the importation
of these plants from Nigeria. The Nigerian custom services
granted the demand of the Abia State University to export2 Journal of Parasitology Research
these materials to the University of Cape Town, South Africa
for research purposes.
2.2. Extraction. The air-dried leaves were reduced into
smaller pieces using a plant blender (Waring, Conn, USA).
Plants were sequentially extracted. This sequential extraction
started with petroleum ether, which helps in reducing the
chlorophyll pigment in these green leaves followed by
dichloromethane extraction, ethyl acetate, methanol, and
water. Each solvent was repeatedly used to extract each
plant for 4-5 times. Plants were extracted for 24 hours, and
during the process the plant material and the solvent were
continuously shaken for adequate mixing on a horizontal
orbit shaker (Labcon, Calif, USA). The resultant mixture
was ﬁltered and the ﬁltrate concentrated under pressure in
aB¨ uchi Rotavapor R-205 (B¨ uchi Labortechnik AG, Switzer-
land), at 24◦C. The concentrated extracts were transferred to
preweighed vials, dried in the hood at room temperature,
and stored at −20◦C until used. The water extracts were
concentrated by freeze drying using a DURA-DRY II instru-
ment (FTS Systems, NY, USA) under a reduced pressure at
−82◦C. The freeze-dried extracts were stored at −20◦C. The
extractive value (% w/w) of the dry extracts was 23.4%.
2.3. Parasite. The chloroquine-sensitive strain (D10) which
was used for this experiment was donated by Dr. A. Cow-
man, Walter and Eliza Hall Institute of Medical Research,
Melbourne, Australia, while the chloroquine resistant strain
(DD2)wasderivedfromIndochina.Theasexualerythrocytic
stages of these parasites were maintained in a continuous
culture using the method of Trager and Jensen [8].
2.4. In Vitro Experimental Plate Setup and Antiplasmodial
Assay Procedure. The antiplasmodial activity of each extract
was evaluated against the chloroquine-sensitive (CQS D10)
and chloroquine-resistant (CQR) strains of P. falciparum
using the parasite lactate dehydrogenase (pLDH) assay as
described by Makler et al. [9]. A stock solution of 2mg/mL
of extract was prepared in 10% methanol (MeOH) (in
deionized water). This was further diluted in complete
medium to attain a ﬁnal concentration of 200μg/mL in
1% MeOH. The stock solutions were prepared on the
assay day. Chloroquine (CQ) (Sigma) was used as the
standard reference drug (positive control). 2mg/mL stock
of CQ (Sigma) was constituted in deionized water and
further diluted in complete medium to a concentration of
200μg/mL.Extractswereseriallydilutedtwofoldincomplete
medium up to 0.195μg/mL using a ﬂat-bottomed, 96-
well microtitre plate (Greiner Bio-One). CQ was tested at
a starting concentration of 100ng/mL or 1000ng/mL for the
sensitive (D10) and resistant (DD2) strains of P. falciparum,
respectively. Unparasitised erythrocyte (RBC) was added to
column 1 (blank) which had no drugs, while parasitized red
blood cells (pRBCs) were added to columns 2–12. The plate
was gassed for 2 minutes (93% N2,4 %C O 2,a n d3 %O 2)a n d
incubated for 48 hours. A ﬁnal hematocrit and parasitemia
of 2% was used for all experiments. The IC50 recorded in
this study with the exception of the screening assay is the
mean of 3 independent experiments. The absorbance of
each well was read using a microplate reader at 590nm.
The percentage parasite survival and the concentration that
inhibits the growth of parasites by 50% were determined
by measuring the conversion of NBT by P. falciparum. This
was achieved by analyzing the readings from the microplate
reader using Microsoft Excel 2002, and the IC50 value which
is the concentration at which the growth of the parasite was
inhibited by 50% was determined using a nonlinear dose
response curve ﬁtting analysis in Graph Pad Prism version
4.
2.5. In Vitro Cytotoxicity Assay. The cytotoxicity assay used
in this study was the method described by Mosmann et
al. [10]. This is a rapid colorimetric assay method for
determining cellular growth and chemosensitivity. It makes
use of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) salt. The mammalian Chinese hamster
ovarian (CHO) cell line was used to investigate cytotoxicity
activity. Emetine (Sigma) was used as the standard reference
drug (control) to establish the cytotoxicity of the sample
against the CHO cell lines. Two mg/mL stock of emetine
was constituted in deionised water and stored at 4◦C. A
10% dilution of stock solution in CM was made in complete
medium to give the highest concentration of 200μg/mL and
the lowest concentration of 0.002μg/mL. These concentra-
tionsweretestedtodeterminethecytotoxicityoftestsamples
against the CHO cells, as well as the IC50 by comparing with
the reference drug emetine. The cell survival was determined
using a microplate reader at 540nm wavelength. The data
was analyzed using Microsoft Excel 2002 and Graph Pad
Prism; version 4 was used for the nonlinear dose response
curve analysis. The IC50 values were given as a mean of
2 or more independent experiments. The selectivity index
(SI), which is the cytotoxicity: antiplasmodial ratio, was
calculated to determine if the recorded activity was due to
the antiplasmodial activity of the test samples or due to
cytotoxicity to CHO cells. The resistance index (RI) for a
drug is the ratio between the IC50 of the resistant values of
a strain to the sensitive strain. The selectivity index (SI) and
the resistance index (RI) were calculated as shown below:
SI = IC50 cytotoxicity/IC50 antiplasmodial activity,
RI = IC50 of resistant strain (DD2)/IC50 of sensitive
strain (D10).
2.6. Bioassay-Guided Fractionation of C. papaya Ethyl
Acetate Fraction
2.6.1. Solid-Phase Extraction (SPE) Procedure. The ethyl
acetate extract which gave the most antiplasmodial activity
was fractionated using the solid-phase extraction (SPE)
procedure. This was carried out with reverse-phase octadecyl
C18 Isolute cartridges (2.6 × 13.0cm, 10g sorbent, IST Ltd,
Anatech, South Africa). Samples of the ethyl acetate extract
from the leaves of C. papaya were dissolved in methanol.
This mixture was diluted to a concentration of 5mg/mL with
a 60% acetonitrile concentration in water (60% ACN:40%Journal of Parasitology Research 3
mH2O). The C18 isolute cartridge was premoistened with
20mL of mH2O and preconditioned with 20mL of the 60%
acetonitrile. A volume of 3mL of this solution was layered
on the top of this cartridge. Samples retained on the sorbent
beds were rinsed with 20mL of mH2O to elute unretained
material. Samples retained on the sorbent beds were eluted
under vacuum through a step-wise gradient with 40mL
of ACN:H2O (20%–100%) at an increasing concentration
of 20%. The eluates were collected in a ﬁtted bottle. The
vacuum pressure was set to control the ﬂow at the rate of
15mL/min. At the end of each run, the cartridge was washed
with 100mL acetone to wash out any remaining material.
T h ec o l l e c t e df r a c t i o n sw e r ec o n c e n t r a t e du n d e rp r e s s u r e
by rotary evaporation at 40◦C and freeze-dried. The freeze-
dried samples were placed in vials and stored at −20◦C.
The 100% ACN fraction was transferred to preweighed vials,
dried in the fume hood, and stored at −20◦C. The in vitro
antiplasmodial activities of these fractions were determined
using the method described earlier in Section 2.4.
2.6.2. High-Pressure Liquid Chromatography (HPLC). The
SPE fraction selected for further puriﬁcation was frac-
tionated on a Shimadzu LC 10AS high-pressure gradient
system. This was equipped with a desktop PC which
runs Shimadzu control software via a Shimadzu CBM10A
communication bus module. Other components of the
HPLC instrument included an automatic sample injector,
two solvent delivery systems (LC10AS pumps), and a diode
array detector (Shimadzu SPDM10A). Compounds were
detected by UV spectra at 210nm, 240nm, and 260nm
as acquired by the diode array detector. The solvents used
include methanol (Scharlau) and acetonitrile (Scharlau),
each of analytical grade. Puriﬁed deionized water (Millipore,
milli-Q water system) was also used. The conditions are
stated in Section 2.6.3.
2.6.3. Semipreparative HPLC Conditions. A semipreparative
HPLCC18 column (Discovery, 25cm ×10mm,5μm,56924-
U Supelco) was used. Samples were chosen based on their
in vitro antiplasmodial activity, as well as their cytotoxic-
ity values. Samples were centrifuged in a microcentrifuge
(Abbott, Germany) at 1000rpm in 5 minutes. The injection
volume was 50μL with a ﬂow rate of 2mL/min over a 30min
run time and a solvent gradient of 20–100% acetonitrile in
water.Theelutiontimeofthepeakswasobserved,noted,and
set up for further collections following multiple injections.
The fractions collected were concentrated using the rotary
evaporator and freeze-dried. Dried samples were tested in
vitro against Plasmodium parasites, and the active peaks
were tested for purity using an analytical HPLC and GC-MS
systems as speciﬁed in Section 2.6.4.
2.6.4. Analytical HPLC and GC-MS Conditions. The purity
of the peaks was monitored by an analytical HPLC using
an octadecyl Silica column (Agilent Eclipse, XDB-C18,4 . 6
× 150mm, 5μm, USA). Separations were accomplished at
29.7◦C with a solvent gradient of 20–100% acetonitrile in
w a t e rf o r3 0m i n u t e sa taﬂ o wr a t eo f1m L / m i n .T h ep u r i t y
and identity of these peaks were further conﬁrmed using
the GC-MS spectrometry. The carrier gas was helium with
a constant ﬂow of 1mL/min. The injection split was 1:5;
the temperature of the injector and the transfer temperature
were 280◦C. The EI ionization energy was 70eV, and the
scanning mass range was m/z 40 to 400 (perﬂuoro-tri-N-
butylamine as mass reference), with a solvent hold of 6
minutes.
3. Results
3.1. In Vitro Assay. The results of the screening assay showed
that the highest antiplasmodial activity was found in the
ethyl acetate (EA) fraction using the chloroquine-sensitive
D10 strain, with IC50 value of 2.6μg/mL when compared to
other solvents (Table 1). In this study, in vitro activities of
≤10μg/mLwereregardedasactive;thus,workwiththeother
extracts was not taken further. Chloroquine used during this
screening showed an IC50 of 8.55 ± 2.81ng/mL in the CQS
D10 strain. The growth of the parasites treated with the ethyl
acetate extract was signiﬁcantly inhibited. Water extracts had
no eﬀect on the growth of the parasite.
The in vitro antiplasmodial and cytotoxicity activities
of the ethyl acetate extract are shown in Table 2. The ethyl
acetate fraction of C. papaya showed a high selectivity for
P. falciparum with a selectivity index of 249.25 and 185.37
against the D10 and DD2 strains, respectively (Table 2). The
D10 strain used in the experiment was found to be CQ-
sensitive with 50% inhibitory concentration (IC50)v a l u eo f
9.21 ± 3.01ng/mL, while the DD2 strain showed IC50 value
of98.5 ±26.1ng/mL.EmetinerecordedIC50 of0.045μg/mL.
3.2. Solid-Phase Extraction (SPE). Fractionation of the ethyl
acetate fraction of C. papaya by solid-phase extraction was
carried out to isolate and identify the active components
(Section 2.6.1). 900mg of ethyl acetate extract was frac-
tionated using the solid-phase extraction (SPE) procedure.
Weights of the diﬀerent fractions and their activity against
the D10 strain of P. falciparum are shown in Table 3.T h e
activity was greatest in the more hydrophobic fractions.
3.3. High-Pressure Liquid Chromatography (HPLC). The
HPLC proﬁle of the C. papaya ethyl acetate SPE fraction
(100% ACN) showed two major peaks. These were isolated
using semipreparative HPLC column. The 100% ACN frac-
tion was further fractionated using HPLC analytical system
and revealed the chromatogram shown in Figure 1.
The recorded activity of the 100% ACN fraction was
very close to the activity of the parent ethyl acetate crude
extract of 2.96μg/mL against P. falciparum (Table 2). Further
puriﬁcation of the 100% ACN fraction using an analytical
HPLC column yielded two major peaks. Peak 1 had IC50so f
3.58μg/mL and 4.40μg/mL against the CQS D10 and CQR
DD2ofP.falciparum,respectively,whilepeak2recordedIC50
values of 6.88μg/mL and 6.80μg/mL against the CQS and
CQR strains of P. falciparum,r e s p e c t i v e l y( Table 4). These
two peaks were less active than the SPE fraction (2.2μg/mL)
shown in Table 3 as well as the ethyl acetate extracts which4 Journal of Parasitology Research
Table 1: The in vitro antiplasmodial activity of Carica papaya leaves extracted with the various solvents using the CQS D10 strain.
Plant botanical name PET IC50 (μg/mL) DCM IC50 (μg/mL) EA IC50 (μg/mL) MEOH IC50 (μg/mL) H2OI C 50 (μg/mL)
C. papaya 16.4 12.8 2.6 10.8 >50.0
PET: petroleum ether; DCM: dichloromethane; EA: ethyl acetate; MEOH: methano; H2O: water.
Table 2: In vitro antiplasmodial activity of Carica papaya on Plasmodium falciparum cultures and toxicity towards the CHO cell line.
Crude extract Solvent IC50 D10 (μg/mL) IC50 DD2 (μg/mL) IC50 CHO (μg/mL) (SI) D10 (SI) DD2 RI
Carica papaya EA 2.96 ± 0.14 3.98 ± 0.42 737.8 ± 0.28 249.25 185.37 1.34
SI = IC50 cytotoxicity/IC50 antiplasmodial activity. RI = IC50 of resistant strain (DD2)/IC50 of sensitive strain (D10).
Table 3: Activities of C. papaya SPE fractions against the CQS D10
strain.
Percentage ACN
fraction
Weight of Fractions
(mg) IC50 (μg/mL)
20% 142.80 >50
40% 295.60 16.55 ± 3.09
60% 329.90 2.52 ± 0.39
80% 482.51 2.69 ± 0.76
100% 369.50 2.24 ± 0.58
0
0.04
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0.12
0.16
5 1 01 52 02 53 03 54 0
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Figure 1: HPLC proﬁles of SPE fraction using C18 column:
agilent XDB C18 RP analytical: 4.6 × 150mm; 5μ particle size (λ
= 236.8nm). HPLC conditions: mobile phase ACN: H2O using
a gradient of 20–100% ACN (30 minutes) 100% ACN hold (3
minutes), 100-20% ACN (2 minutes) 20% ACN hold (5 minutes),
Injectionvolume:30μLof1mg/mL,columntemp.:30◦C,ﬂowrate:
1mL/min.
had an IC50 of 2.96μg/mL against the CQS strain and
3.98μg/mL against the CQR strain (Table 2).
3.4. GC-MS Analysis. Peaks 1 and 2 were identiﬁed as essen-
tial fatty acids 9,12,15-octadecatrienoic acid (linolenic acid)
and 9,12-octadecadienoic acid (linoleic acid), respectively,
(Figures 2 and 3) using the GC-MS spectrometry. These
essential fatty acids belonging to the C18 fatty acid diﬀer
structurally in the position and degree of unsaturation.
An attempt was made to characterize and elucidate
the structures of compounds 1 and 2 using the 1D and
2D NMR spectrometric methods. The 1Ha n d13Cs p e c t r a
used in this study are the most widely used 1D NMR
techniques. 1H–NMR spectra can identify the protons in
O
HO
Figure 2: 9,12,15-octadecatrienoic acid (linolenic acid).
O
HO
Figure 3: 9,12-octadecadienoic acid (linoleic acid).
molecules. The number of 13C signals identiﬁed compounds
1 and 2 as unsaturated aliphatic fatty acids. Generally,
1D NMR helps in identiﬁcation of aliphatic systems and
determination of the degree of unsaturation, as well as the
identiﬁcation of functional groups. Further characterization
of compounds 1 and 2 using 2-D NMR techniques which
included HSQC, HMQC, and gCOSY met with diﬃculties
due to the similarity in chemical shift of most of the
methylenegroupsandoftheoleﬁnicdoublebonds.However,
two groups could be unequivocally identiﬁed. The CH2 at
position 2 gave a triplet at δ2.30, with a coupling constant
of 7.50Hz. Similarly the CH3 at position 18 gave a triplet
at δ0.90 with a coupling constant of 3.6Hz. The multiple
peaks for compound 1, which were at 1H 5.27–5.38 (9, 12,
15 H), were connected to carbon signals at 13C 131.0–127.0
in the HSQC spectrum, while in compound 2 the multiple
peaks at 1Hp e a k s ,w h i c hw e r ea tδH 5.30–5.39 (9, 12 H)
were linked to the carbon signals at 13C 129.0–130.6 in the
HSQCspectrum.Duetothecomplexityoftheresonancesfor
the oleﬁnic protons in a similar chemical environment, the
purity of these compounds was further conﬁrmed using the
GC-MS spectrometry. Gas chromatography is routinely used
to analyze fatty acids due to its high resolution, speed, and
sensitivity. The GC-MS spectrum of compound 1 shows the
molecular ion at m/z 278. In compound 1 two losses of CH2
groups were evident (m/z 135–m/z 121; m/z 93–79), while in
compound 2 the molecular ion was shown at m/z 280. Two
losses of CH2 groups were also evident (m/z 96–m/z 82; m/z
82–67) in the spectrum of compound 2.Journal of Parasitology Research 5
Table 4: In vitro activity of peaks 1 and 2.
Sample name D10 IC50 (μg/mL) DD2 IC50 (μg/mL) CHO IC50 (μg/mL) SI-D10 CHO SI-DD2 CHO RI
Peak 1 3.58 ± 0.22 4.40 ± 1.10 54.70 ± 2.01 15.27 12.43 1.22
Peak 2 6.88 ± 0.02 6.80 ± 1.21 51.16 ± 5.52 7.43 7.52 0.98
SI = IC50 cytotoxicity/IC50 antiplasmodial activity. RI = IC50 of resistant strain (DD2)/IC50 of sensitive strain (D10).
4. Discussion
In this study antiplasmodial activities of ≤10μg/mL were
regarded as active. According to Gessler et al. [11] very good
extracts should display IC50so f≤10μg/mL. Water extracts
showed no activity with IC50 values >50μg/mL. Irungu et
al. [12] demonstrated similar results in work with 14 plants.
Bhat and Surolia [13] recorded no activity of the water
extracts of C. papaya. The petroleum ether extracts of the
rind and pulp of the unripe fruit of C. papaya demonstrated
antiplasmodial activities with IC50 values of 15.19μg/mL
and 18.09μg/mL, respectively [13]. Their observations using
F C K2( al o c a ls t r a i no fP. falciparum from Karnataka
state, India) were similar to the IC50 value of 16.36μg/mL
from the petroleum ether extracts of the leaves of C.
papaya investigated in this study using the D10 strain of P.
falciparum.
In the present study, C. papaya ethyl acetate extract
showed a high selectivity 249 and 185 against P. falciparum-
sensitive (D10) and P. falciparum-resistant (DD2) strains,
respectively. This indicates good speciﬁcity against P. falci-
parum and also shows that the recorded activity of the C.
papaya extract was not due to a nonspeciﬁc cytotoxic eﬀect.
In general, an SI ≥10 signiﬁes that biological eﬃcacy is not
the result of in vitro cytotoxicity [14, 15]. The activity of the
ethyl acetate extracts against the chloroquine-sensitive (D10)
and chloroquine-resistant (DD2) strains of P. falciparum
did not diﬀer signiﬁcantly. The control drug for the in
vitro antiplasmodial experiment was chloroquine, while that
for cytotoxicity experiment was emetine [15–17]. Previous
studies have shown that C. papaya ameliorates vaginal
disturbances due to Trichomonas vaginalis [18]. It has been
reported to show anti-inﬂammatory properties [19]. The
anthelminthic activity of C. papaya is traceable to the pres-
ence of carpain (alkaloid), carpasemine (benzylthiourea),
and benzylisothiocyanate [20]. The latex of C. papaya at a
dose of 8g/kg has been found to be 84.5% eﬀective against
Heligmosomoides polygyrus (in mice) and Ascaris suum in
pigs [7]. These researchers reported a dose response activity
ofpapaya latexandstated thatthecalculatedED100 of papaya
latex against adult Heligmosomoides polygyrus was 12g/kg
using probit analysis [7]. A previous study demonstrated
the potency and cost eﬀectiveness of C. papaya fruit when
appliedtopicallyinthetreatmentofchroniculcersinJamaica
[21]. In a recent study, C. papaya was listed as one of the
plants used in the treatment of leishmaniasis [22]. It has
been reported as accessible, nontoxic, and prophylactic and
to be a promising monotherapy against intestinal parasitosis
in tropical countries [23].
The activity of the ethyl acetate extract of C. papaya was
stronger than that of the isolated compounds in this study.
This observation suggests that the various compounds in
the mixture may act synergistically. Neither peak showed
signiﬁcant cytotoxicity. In this study, the in vitro activity
of linolenic acid which has three double bonds was higher
than linoleic acid which has two double bonds. There was
no signiﬁcant diﬀerence in the activity of these compounds
in the D10 and DD2 strains used in this study. The
antiplasmodial activity of the unsaturated fatty acids has
been reported to increase as the degree of unsaturation
increases [24, 25]. These researchers reported the marked in
vitro growth inhibition of P. falciparum by docosahexaenoic
acid (C22-6,n-3), docosahexaenoic acid methyl ester (C22-6,n-3
methyl ester), eicosapentaenoic acid (C20-5,n-3), arachidonic
acid (C20-4,n-6), and linoleic acid (C18-2,n-6). They reported
thatoleicacid(C18-1,n-9)anddocosanoicacid(C22-0)hadvery
little eﬀect on parasite growth inhibition [24]. In their work,
the unsaturated fatty acids C22:6,n-3 and C20:4,n-6 showed
signiﬁcant in vitro antiplasmodial activity but C22:0 was
inactive.
The introduction of a single double bond into the mono-
unsaturated fatty acid greatly enhanced the antiplasmodial
eﬀects of the molecules [24]. Further work on a C18 fatty
acid (scleropyric acid) isolated from the twigs of Scleropyrum
wallichianum Arn. of the family Santalaceae Suksamrarn
et al. [26] reported antiplasmodial activity with an IC50
value of 7.2μg/mL against K1 (CQR) strain of P. falciparum,
similar to the antiplasmodial activity of linoleic acid with
an IC50 of 6.80μg/mL against the DD2 (CQR) strain in this
study. Further study documented the antiplasmodial activi-
ties with IC50 < 5μg/mL showed by fatty acids isolated from
Croton lobatus against Plasmodium falciparum K1 (CQR)
strain [14]. The fatty acids they isolated included (Z.,Z.,Z.)-
9,12,15-octadecatrienoic acid methyl ester, 8,11,17,21-te-
tramethyl-(E.,E.,E.,E.)-8,10,17,21-tetraentetracosanoic acid,
(E.)-3-(4-methoxy-phenyl)-2-phenyl-acrylic acid, and be-
tulinic acid [14]. A previous study reported that the neu-
trophil-mediated killing of the asexual blood forms of
Plasmodium falciparum could be enhanced by fatty acids
[25]. These essential fatty acids are recently used as health
supplements due to the health beneﬁts associated with them
[27, 28]. The lipophilic nature of these acids which were
the active components isolated from C. papaya ethyl acetate
extract in the present study may help explain the poor activ-
ity exhibited by the aqueous extract in a recent study [29].
In conclusion, ethyl acetate fraction ofC. papaya demon-
strated the greatest antiplasmodial activity when compared
to the activities of the SPE fractions and the isolated
compounds. This suggests an enhancement of activity by
other chemical constituents present in the extract which may
have acted synergistically. The hot water extraction of these
plants used by the traditional healers could extract lower6 Journal of Parasitology Research
concentrations of these active lipophilic components, but
may not be available at therapeutic doses. This result may
help explain the increase in parasite survival despite contin-
uous treatment with herbal remedies. Hot water extracts of
plants can be diﬃcult to evaluate for antiplasmodial activity
as they can contain large amounts of saponins which have
nonspeciﬁc antiplasmodial activity. An investigation of the
in vivo schizontocidal activity of the fractions is necessary
since in vitro activity does not mean that the chemical
compound is equally active in vivo [30]. This is because
some physiological factors and immune response that are
inevitable in an in vivo system are not applicable in the in
vitro experiment.
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